• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Alzheimer’s disease

brain
Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory

Relyvrio/Albrioza: New Drug for Amyotrophic Lateral Sclerosis Treatment

September 29, 2022September 30, 2022

Amylyx Pharmaceuticals proposed mixture of sodium phenylbutyrate and tauroursodeoxycholic acid for ALS treatment.

Brain.
Posted inNeuroscience, New Drugs, Regulatory

Oligomannate: Finally New Drug to Treat Alzheimer’s Disease

April 26, 2022September 8, 2022

Innovative Chinese medicine eliminates gut microbiota dysbiosis, and it helps slow the progression of dementia in Alzheimer’s disease.

agitation
Posted inNeuroscience, New Drugs, Regulatory

Igalmi: New Drug for Agitation in Schizophrenia and Bipolar Disorder

April 7, 2022September 8, 2022

BioXcel Therapeutics has offered a fast-action mouth-dissolving sublingual film formulation of dexmedetomidine.

brain
Posted inClinical Trials, Neuroscience

Buntanetap: Breakthrough in Treatment of Alzheimer’s and Parkinson’s

January 11, 2022September 8, 2022

Buntanetap acts simultaneously on three neurotoxic proteins responsible for neurodegenerative disorders: amyloid beta, alpha-synuclein, and tau protein.

Bit Bio: Mass and Problem-Free Production of Any Human Cells
Posted inAutoimmune Diseases, Neuroscience, Oncology, Pharma & Biotech

Bit Bio: Mass and Problem-Free Production of Any Human Cells

November 11, 2021September 8, 2022

Human cells are needed for scientific research, development of new drugs, and creation of cell therapies.

obesity
Posted inMetabolism, New Drugs, Regulatory

Wegovy: Most Effective Drug for Weight Loss

June 9, 2021September 8, 2022

Semaglutide can help you lose 15% of your excess weight in a year. And even more.

Masitinib for Alzheimer’s Disease: It Did Work!
Posted inClinical Trials, Neuroscience

Masitinib for Alzheimer’s Disease: It Did Work!

April 12, 2021September 8, 2022

Masitinib by AB Science has curbed cognitive deterioration in Alzheimer-type dementia. And that’s a new hope.

Posts navigation

1 2 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News